Eisai
4523.T
#2159
Rank
NZ$15.57 B
Marketcap
NZ$55.26
Share price
1.81%
Change (1 day)
10.49%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): NZ$1.42

According to Eisai's latest financial reports the company's current EPS (TTM) is NZ$1.45. an increase over its 2024 EPS that were of NZ$1.64.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025NZ$1.8311.85%
2024NZ$1.64-32.63%
2023NZ$2.435.52%
2022NZ$2.30-74.01%
2021NZ$8.86-66.58%
2020NZ$26.5098.24%
2019NZ$13.3717.01%
2018NZ$11.4237.78%
2017NZ$8.29-27.62%
2016NZ$11.4535.33%
2015NZ$8.46-2.82%
2014NZ$8.71-27.66%
2013NZ$12.04-27.49%
2012NZ$16.61-12.67%
2011NZ$19.0288.08%
2010NZ$10.11-11.06%
2009NZ$11.37-390.15%
2008NZ-$3.92-127.78%
2007NZ$14.1111.78%
2006NZ$12.624.38%
2005NZ$12.097.4%
2004NZ$11.2643.03%
2003NZ$7.8725.09%
2002NZ$6.2952.67%
2001NZ$4.1269.76%
2000NZ$2.43